18F-fallypride binding potential in patients with schizophrenia compared to healthy controls

scientific article published on 23 July 2010

18F-fallypride binding potential in patients with schizophrenia compared to healthy controls is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SCHRES.2010.03.043
P932PMC publication ID3278159
P698PubMed publication ID20655709
P5875ResearchGate publication ID45286646

P50authorDouglas S. LehrerQ47826303
P2093author name stringBradley T Christian
Monte S Buchsbaum
Binquan Wang
Bingzhi Shi
King-Wai Chu
Brian Merrill
Cemil Kirbas
Shawn Sidhu
Meicheng Chiang
Holly Short
P2860cites workThe dopamine hypothesis of schizophrenia: version III--the final common pathwayQ22242827
Reduced language lateralization in first-episode schizophrenia: an fMRI index of functional asymmetry.Q30374652
Task-modulated "what" and "where" pathways in human auditory cortexQ30478108
Visualization of extrastriatal dopamine D2 receptors in the human brainQ48407407
Midbrain dopamine D2/3 receptor binding in schizophreniaQ48493567
Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patientsQ48495191
Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference regionQ48516606
Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's diseaseQ48559810
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and genderQ48597393
Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers AssociationQ48615927
Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem studyQ48669559
Cortical intercorrelations of frontal area volumes in schizophreniaQ48827273
Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophreniaQ48891976
Mental imagery vividness as a trait marker across the schizophrenia spectrum.Q51870775
White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging.Q51899159
Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.Q52520482
Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 – a test-retest analysisQ60714085
Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperoneQ72676838
Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brainQ73110283
Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems!Q83564840
Tuning in to the voices: a multisite FMRI study of auditory hallucinationsQ30484435
Compartmental Analysis of Diprenorphine Binding to Opiate Receptors in the Rat in vivo and its Comparison with Equilibrium Data in vitroQ33331804
Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophreniaQ33671075
Feeling unreal: a PET study of depersonalization disorderQ33923746
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophreniaQ33963430
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallyprideQ34011162
Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptorsQ34151747
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjectsQ34183875
Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracerQ34301516
Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophreniaQ34413325
Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patientsQ34429796
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophreniaQ34528409
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenicsQ34559171
The role of extrastriatal dopamine D2 receptors in schizophreniaQ36472028
Distribution volume ratios without blood sampling from graphical analysis of PET dataQ36817029
The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imagingQ37113776
The mediodorsal thalamic nucleus and schizophreniaQ37316608
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatumQ39488987
Distribution of the dopamine innervation in the macaque and human thalamusQ40264301
Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: Positron emission tomography studiesQ40739170
Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallyprideQ40931384
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]racloprideQ41173321
Strategies to improve neuroreceptor parameter estimation by linear regression analysisQ42526696
Brain structural changes in schizophrenia patients with persistent hallucinations.Q44283754
Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patientsQ44436592
Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.Q44646513
Low dopamine d(2) receptor binding in subregions of the thalamus in schizophreniaQ44915190
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.Q44933445
Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia.Q45972374
Rapid Automated Algorithm for Aligning and Reslicing PET ImagesQ46171761
Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.Q46391580
Abnormal effective connectivity of dopamine D2 receptor binding in schizophreniaQ46458232
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humansQ46764291
Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomographyQ46930730
MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomesQ48135275
Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approachQ48212090
Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up studyQ48258798
[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference regionQ48334899
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomographyQ48374750
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophreniaQ48381678
P433issue1-3
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)43-52
P577publication date2010-07-23
P1433published inSchizophrenia ResearchQ7431607
P1476title18F-fallypride binding potential in patients with schizophrenia compared to healthy controls
P478volume122

Reverse relations

cites work (P2860)
Q55305236Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies.
Q37825633Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems
Q46026441Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis.
Q34527656Pathway-Specific Dopamine Abnormalities in Schizophrenia
Q38232366The neurobiology and treatment of first-episode schizophrenia
Q48010897The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [(18)F]fallypride
Q47566341Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Search more.